In the present study, we evaluated PD-L1 expression in thymomas and thymic carcinomas using two types of antibody clones, SP142 and SP263, and compared the expression rates and examined the prognostic implications of PD-L1 expression. This evidence concerns the gene CD274 and thymic carcinoma.